Amneal Pharmaceuticals Private Limited — Chloroquine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Chloroquine · $950.0K export value · DGFT Verified
Amneal Pharmaceuticals Private Limited is the #7 Indian exporter of Chloroquine with $950.0K in export value and 19 verified shipments. Amneal Pharmaceuticals Private Limited holds a 0.6% market share in Chloroquine exports across 2 countries. The company exports 28 pharmaceutical products worth $106.5M across 19 therapeutic categories.
Amneal Pharmaceuticals Private Limited — Chloroquine Export Profile: Buyers & Destinations
Where Does Amneal Pharmaceuticals Private Limited Export Chloroquine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $606.0K | 18 | 85.8% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 14.2% |
| CHINA | $206 | 1 | 0.0% |
Amneal Pharmaceuticals Private Limited exports Chloroquine to 3 countries. The largest destination is UNITED STATES accounting for 85.8% of Amneal Pharmaceuticals Private Limited's Chloroquine shipments, followed by UNITED STATES OF AMERICA (14.2%) and CHINA (0.0%). These destinations reflect Amneal Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Chloroquine from Amneal Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMNEAL PHARMACEUTICALS, LLC (KY) | UNITED STATES | $446.0K | 14 |
| XXNEAXXEU XXMITXX | UNITED STATES OF AMERICA | $100.0K | 2 |
| AMNEAL EU LIMITED | UNITED STATES | $100.0K | 2 |
| AMNEAL PHARMACEUTICALS LLC | UNITED STATES | $59.9K | 2 |
| SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPME | CHINA | $206 | 1 |
Amneal Pharmaceuticals Private Limited supplies Chloroquine to 5 buyers globally. The largest buyer is AMNEAL PHARMACEUTICALS, LLC (KY) (UNITED STATES), followed by XXNEAXXEU XXMITXX (UNITED STATES OF AMERICA) and AMNEAL EU LIMITED (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Chloroquine Export Value and How Much Does Amneal Pharmaceuticals Private Limited Contribute?
India exported $40.7M worth of Chloroquine through 5,437 shipments from 287 suppliers to 120 countries, serving 774 buyers globally. Amneal Pharmaceuticals Private Limited contributes $950.0K to this total, accounting for 0.6% of India's Chloroquine exports. Amneal Pharmaceuticals Private Limited ships Chloroquine to 3 countries through 5 buyers.
What Is the Average Shipment Value for Amneal Pharmaceuticals Private Limited's Chloroquine Exports?
Amneal Pharmaceuticals Private Limited's average Chloroquine shipment value is $50.0K per consignment, based on 19 shipments totaling $950.0K. The largest destination is UNITED STATES (85.8% of Amneal Pharmaceuticals Private Limited's Chloroquine exports).
How Does Amneal Pharmaceuticals Private Limited Compare to Other Indian Chloroquine Exporters?
Amneal Pharmaceuticals Private Limited ranks #7 among 287 Indian Chloroquine exporters with a 0.6% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($19.1M), ZYDUS LIFESCIENCES LIMITED ($13.0M), CADILA HEALTHCARE LIMITED ($2.0M). Amneal Pharmaceuticals Private Limited processed 19 shipments to 2 destination countries.
What Chloroquine Formulations Does Amneal Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Chloroquine Phosphate Tablets,USP 250 mg | $106.9K | 3 |
| Chloroquine Phosphate Tablets,USP 500 mg | $100.4K | 3 |
| HYDROXYCHLOROQUINE SULFATETABLETS | $100.0K | 2 |
| HYDROXYCHLOROQUINE SULFATETABLETS, | $100.0K | 2 |
| CHLOROQUINE PHOSPHATE TABLETS,USP 250 MGNDC 00115-2790-06 FDA PRODUCT CODE 61 AC A 06 ANDA # 080880 UNIT PACK 50 | $61.5K | 2 |
| CHLOROQUINE PHOSPHATE TABLETS,USP 500 MGNDC 00115-7010-09 FDA PRODUCT CODE 61 AC A 06 ANDA # 040516 UNIT PACK 25 | $57.2K | 2 |
| CHLOROQUINE PHOSPHATE TABLETS,USP 500 MG | $31.7K | 1 |
| CHLOROQUINE PHOSPHATE TABLETSUSP 250 MGNDC 00115-2790-06 FDA PRODUCT CODE 61 AC A 06 ANDA # 080880 UNIT PACK 50 | $31.6K | 1 |
| CHLOROQUINE PHOSPHATE TABLETS,USP 250 MG | $31.5K | 1 |
| CHLOROQUINE PHOSPHATE TABLETS USP 250 MGNDC 00115-2790-06 FDA PRODUCT CODE 61 AC A 06 ANDA# 040516 UNIT PACK 50 | $29.4K | 1 |
Amneal Pharmaceuticals Private Limited exports 13 distinct Chloroquine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Chloroquine Phosphate Tablets,USP 250 mg with 3 shipments worth $106.9K.
Regulatory Requirements: Exporting Chloroquine to Key Markets
What Amneal Pharmaceuticals Private Limited must comply with to export Chloroquine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Amneal Pharmaceuticals Private Limited Compare to Nearest Chloroquine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | CADILA HEALTHCARE LIMITED | $2.0M | 41 | 5 | $50.0K |
| 5 | INTAS PHARMACEUTICALS LIMITED | $1.1M | 21 | 3 | $50.0K |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED ★ | $950.0K | 19 | 2 | $50.0K |
| 8 | NITIN LIFESCIENCES LIMITED | $854.3K | 50 | 1 | $17.1K |
| 9 | SYNCOM FORMULATIONS (INDIA) LIMITED | $713.0K | 113 | 7 | $6.3K |
Amneal Pharmaceuticals Private Limited ranks #7 among 287 Indian Chloroquine exporters. Average shipment value of $50.0K compared to the market average of $141.7K. The closest competitors by value are CADILA HEALTHCARE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Chloroquine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,431 | 26.3% |
| SAHAR AIR | 1,199 | 22.1% |
| DELHI AIR CARGO ACC (INDEL4) | 657 | 12.1% |
| Bombay Air | 359 | 6.6% |
| DELHI AIR | 325 | 6.0% |
| MUNDRA SEA | 156 | 2.9% |
| NHAVA SHEVA SEA (INNSA1) | 136 | 2.5% |
| Delhi Air | 127 | 2.3% |
What Other Antimalarial & Antiparasitic Products Does Amneal Pharmaceuticals Private Limited Export?
Amneal Pharmaceuticals Private Limited also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Amneal Pharmaceuticals Private Limited's Chloroquine Exports
Amneal's export operations are navigating a complex geopolitical landscape. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, escalating shipping costs and transit times for Indian pharmaceutical exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and increased expenses.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies like Amneal to strengthen their presence in the U.S. market. With the U.S. seeking to diversify its supply chains, Indian exporters are well-positioned to fill the gap, provided they meet stringent regulatory standards.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Amneal's partnership with Orion Corporation to commercialize products in Europe underscores the importance of adhering to these regulations to ensure market access and maintain credibility.
Amneal Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Amneal. In August 2025, the U.S. FDA issued a warning letter to Amneal Pharmaceuticals Private Limited's Gujarat facility, citing significant violations of Current Good Manufacturing Practice (CGMP) regulations, including inadequate investigations into particulate contamination in sterile injectables. (fda.gov) Addressing these compliance issues is crucial for sustaining export operations and upholding the company's reputation in global markets.
About Amneal Pharmaceuticals Private Limited
Amneal Pharmaceuticals Private Limited exports 28 products worth $106.5M. Beyond Chloroquine, top products include Iron, Spironolactone, Gabapentin, Potassium, Naproxen. View the complete Amneal Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Chloroquine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Chloroquine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Amneal Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 21 individual customs records matching Amneal Pharmaceuticals Private Limited exporting Chloroquine, covering 13 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 120+ countries, 774+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Chloroquine Export Data from Amneal Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Amneal Pharmaceuticals Private Limited's Chloroquine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Amneal Pharmaceuticals Private Limited
Full Company Profile →
28 products · $106.5M total trade · 19 categories
Chloroquine Stats
Company Overview
Top Products by Amneal Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Amneal Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Chloroquine. For current shipment-level data, contact TransData Nexus.